Evidence map›Paper›PMID 40016528›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2025

Prognostic value of [

Chunxia Qin, Yiru Fu, Xiao Zhang, Mengting Li, Weiwei Ruan, Yongkang Gai, Xiaoli Lan

Abstract readEvaluation Study
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chunxia Qin *Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, 430022, China.
Yiru Fu *Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, 430022, China.
Xiao ZhangDepartment of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, 430022, China.
Mengting LiDepartment of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, 430022, China.
Weiwei RuanDepartment of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, 430022, China.
Yongkang GaiDepartment of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, 430022, China.
Xiaoli LanDepartment of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, 430022, China. xiaoli_lan@hust.edu.cn.ORCID 0000-0002-7263-7399

Funding

Hubei Province Science and Technology Innovation Team [2022] No. 72Key Project of Hubei Province Natural Science Foundation 2021CFA008National Natural Science Foundation of China 82030052National Natural Science Foundation of China 82171985
6 · The paper itself

Abstract

purposeGallium-68-labeled fibroblast activation protein inhibitor ([

methodsWe retrospectively analyzed patients with gastric cancer who underwent [

resultsEighty-six patients (median age 59 years) were included. Thirty-five patients experienced disease progression, and 26 of them died. Univariable analysis revealed SUVmax, FTV, TLF, TBR, HF and CV were significant prognostic factors for both OS and PFS. In multivariate Cox regression analysis, a nomogram model for OS was established, incorporating body mass index (BMI) and CV as independent predictors. The time-dependent C-index of the nomogram model > 0.75 indicates good predictive performance. When predicting PFS, a stratified analysis was performed based on distant metastasis, FTV was an independent prognostic factor among patients without distant metastasis.

conclusionCV and FTV, derived from [

Indexed as

CarcinomaPositron-Emission TomographyQuinolinesStomachStomach NeoplasmsAdultAgedAged, 80 and overDisease ProgressionFemaleFollow-Up StudiesGallium RadioisotopesHumansKaplan-Meier EstimateMagnetic Resonance ImagingMale68Ga-FAPIGallium RadioisotopesQuinolinesFibroblast activation protein inhibitorGastric cancerPositron emission tomographyPrognosis

Identifiers

PMID40016528

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.